BGPT: Meta-analysis: Assess evidence strength for phytochemical bioactivity claims in reviewed UAE CWR taxa (tiered review + reproducibility risks)

Explore by Goal

Quick Analysis Plan Copied

The supplied evidence records cannot support this meta-analysis: all claim-level records, clinical trial entries, and research data concern EGFR signaling, LDOC1, and NSCLC therapeutics, with none addressing UAE crop wild relative (CWR) taxa, phytochemicals, or their bioactivity claims.

Long Analysis Plan

Evidence Mismatch: Meta-Analysis Cannot Proceed as Specified

The query requests a tiered review of phytochemical bioactivity evidence in UAE crop wild relative taxa, but every supplied source is off-topic: the primary research record concerns LDOC1 regulation of EGFR trafficking in NSCLC with a 200-patient retrospective cohort, mechanistic cell-line work in PC9 and HCC827, and gefitinib IC50 data ; the remaining records cover EGFR copy-number screening, FUT8-mediated fucosylation in antiviral immunity, CIN85 phosphorylation, EGFR-TKI comparisons, and EGFR-targeted nanoparticles.

The clinical trial entries address tart cherry, dried apple, plant sterols, and mango — dietary phytochemical interventions, but not UAE CWR taxa specifically.

To perform this analysis, records are needed that report: (1) taxon identity and phytochemical(s) per UAE CWR species, (2) assay type and effect size, (3) study design tier (in vitro/in vivo/human), and (4) reproducibility metadata (raw data, protocols, blinding). Without these, any tiering or scoring would be fabrication. Confidence that this verdict is correct: high — no supplied record mentions UAE flora, CWR taxa, or relevant phytochemistry.

Feedback:

Updated: September 14, 2026

Top Data Sources Export MCP

1. LDOC1 interacts with clathrin adaptors AP1M1 and AP2M1 to regulate EGFR internalization and recycling, modulating EGFR signaling and gefitinib response in EGFR-mutant NSCLC, with LDOC1 loss promoting RTK activation and gefitinib resistance while associating with poorer patient outcomes. [2024]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

2. This study demonstrates that pSTAT3 transactivates EGFR to maintain EGFR protein homeostasis and contributes to resistance against EGFR tyrosine kinase inhibitors in non-small cell lung cancer cells. [2024]

8QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

3. This study investigates the relationship between EGFR gene copy number alterations and EGFR mutation status in lung adenocarcinoma, concluding that EGFR gene copy number as detected by SISH is not a reliable screening tool for selecting patients for EGFR mutation testing. [2014]

7QualityResults Limitations Context Blindspots Methods Sample Data

↗ Paper Review ↗ Full Paper

4. A comprehensive review of EGFR pathway alterations in NSCLC, detailing activating EGFR mutations, copy-number changes, downstream signaling, predictive biomarkers for EGFR-targeted therapies, and mechanisms of resistance, with emphasis on the need for integrated molecular stratification for personalized treatment. [2011]

8QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

5. The study shows that hepatitis C virus (and other enveloped viruses) upregulates host FUT8 to increase EGFR core fucosylation, activating EGFR-JAK1-STAT3 signaling that recruits Trim40 to promote RIG-I degradation and suppresses type I interferon responses, with FUT8 inhibition or hepatic Fut8 silencing reducing RNA viral replication in vitro and in vivo, revealing a viral immune evasion mechanism and potential antiviral target. [2024]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

Key Insight

Pipeline-on-wrong-domain failure: an otherwise rigorous claim-level evidence extraction was performed entirely on EGFR/NSCLC literature, demonstrating that automated record collection can silently diverge from the query domain.

Keep Exploring

Which UAE crop wild relative taxa have published phytochemical bioactivity studies meeting Cochrane-tier inclusion criteria, and how many are in vitro only?

What reproducibility metrics (protocol sharing, raw data deposit, independent replication) exist for bioactivity studies of Middle Eastern wild plant phytochemicals?

How should tiered evidence frameworks weight in vitro IC50 results against absence of human trials when assessing wild crop relative medicinal claims?

Science Art

Meta-analysis: Assess evidence strength for phytochemical bioactivity claims in reviewed UAE CWR taxa (tiered review + reproducibility risks) Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I default to cautious refusal-to-fabricate when domain-matched data is absent, which protects rigor but may under-deliver for users expecting best-effort frameworks built on generic knowledge.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Analysis Plan Copied

Long Analysis Plan

Evidence Mismatch: Meta-Analysis Cannot Proceed as Specified

Top Data Sources Export MCP

1. LDOC1 interacts with clathrin adaptors AP1M1 and AP2M1 to regulate EGFR internalization and recycling, modulating EGFR signaling and gefitinib response in EGFR-mutant NSCLC, with LDOC1 loss promoting RTK activation and gefitinib resistance while associating with poorer patient outcomes. [2024]

2. This study demonstrates that pSTAT3 transactivates EGFR to maintain EGFR protein homeostasis and contributes to resistance against EGFR tyrosine kinase inhibitors in non-small cell lung cancer cells. [2024]

3. This study investigates the relationship between EGFR gene copy number alterations and EGFR mutation status in lung adenocarcinoma, concluding that EGFR gene copy number as detected by SISH is not a reliable screening tool for selecting patients for EGFR mutation testing. [2014]

6. Src-mediated phosphorylation of CIN85 after EGF stimulation promotes CIN85 binding to the E3 ligase c-Cbl, enhancing EGFR ubiquitination and sorting into multivesicular bodies for degradation, whereas preventing CIN85 phosphorylation traps EGFR in early endosomes and delays degradation. [2012]

Ask a Follow-Up

Key Insight

Pipeline-on-wrong-domain failure: an otherwise rigorous claim-level evidence extraction was performed entirely on EGFR/NSCLC literature, demonstrating that automated record collection can silently diverge from the query domain.

Keep Exploring

Which UAE crop wild relative taxa have published phytochemical bioactivity studies meeting Cochrane-tier inclusion criteria, and how many are in vitro only?

What reproducibility metrics (protocol sharing, raw data deposit, independent replication) exist for bioactivity studies of Middle Eastern wild plant phytochemicals?

How should tiered evidence frameworks weight in vitro IC50 results against absence of human trials when assessing wild crop relative medicinal claims?

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I default to cautious refusal-to-fabricate when domain-matched data is absent, which protects rigor but may under-deliver for users expecting best-effort frameworks built on generic knowledge.

Stay current without chasing every paper.

My BGPT

Trending

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Analysis Plan Copied

Long Analysis Plan

Evidence Mismatch: Meta-Analysis Cannot Proceed as Specified

Top Data Sources ExportMCP

1. LDOC1 interacts with clathrin adaptors AP1M1 and AP2M1 to regulate EGFR internalization and recycling, modulating EGFR signaling and gefitinib response in EGFR-mutant NSCLC, with LDOC1 loss promoting RTK activation and gefitinib resistance while associating with poorer patient outcomes. [2024]

2. This study demonstrates that pSTAT3 transactivates EGFR to maintain EGFR protein homeostasis and contributes to resistance against EGFR tyrosine kinase inhibitors in non-small cell lung cancer cells. [2024]

3. This study investigates the relationship between EGFR gene copy number alterations and EGFR mutation status in lung adenocarcinoma, concluding that EGFR gene copy number as detected by SISH is not a reliable screening tool for selecting patients for EGFR mutation testing. [2014]

6. Src-mediated phosphorylation of CIN85 after EGF stimulation promotes CIN85 binding to the E3 ligase c-Cbl, enhancing EGFR ubiquitination and sorting into multivesicular bodies for degradation, whereas preventing CIN85 phosphorylation traps EGFR in early endosomes and delays degradation. [2012]

Ask a Follow-Up

Key Insight

Pipeline-on-wrong-domain failure: an otherwise rigorous claim-level evidence extraction was performed entirely on EGFR/NSCLC literature, demonstrating that automated record collection can silently diverge from the query domain.

Keep Exploring

Which UAE crop wild relative taxa have published phytochemical bioactivity studies meeting Cochrane-tier inclusion criteria, and how many are in vitro only?

What reproducibility metrics (protocol sharing, raw data deposit, independent replication) exist for bioactivity studies of Middle Eastern wild plant phytochemicals?

How should tiered evidence frameworks weight in vitro IC50 results against absence of human trials when assessing wild crop relative medicinal claims?

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I default to cautious refusal-to-fabricate when domain-matched data is absent, which protects rigor but may under-deliver for users expecting best-effort frameworks built on generic knowledge.

Stay current without chasing every paper.

My BGPT

Trending

Top Data Sources Export MCP